Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome

Get in touch with RARE Concierge.

Contact RARE Concierge

Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome

Synonyms: CMT-deafness-intellectual disability syndrome | Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome | Hereditary motor and sensory neuropathy with deafness, intellectual disability and absent sensory large myelinated fibers | Hereditary motor and sensory neuropathy with hearing loss, intellectual disability and absent sensory large myelinated fibers

Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome is a rare demyelinating hereditary motor and sensory neuropathy characterized by early-onset slowly progressive distal muscular weakness and atrophy with no sensory impairment congenital sensorineural deafness and mild intellectual disability (with absence of normal speech development). The absence of large myelinated fibers on sural nerve biopsy is equally characteristic of the disease.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Hereditary Neuropathy Foundation

Hereditary Neuropathy Foundation (HNF) is a non-profit 501(c)3 organization which mission is to increase awareness and accurate diagnosis of Charcot-Marie-Tooth (CMT) and related inherited neuropathies, support patients and families with critical information to improve quality of life, and fund research that will lead to treatments and cures.

Clinical Trials

For a list of clinical trials in this disease area, please click here.